Project 2: Effective Risk Communicafion on New and Emerging Tobacco p150-191
Ribisl, Kurt M.
University of North Carolina Chapel Hill, Chapel Hill, NC, United States
See 54 grants from Kurt Ribisl
See 34239 grants from University of North Carolina Chapel Hill
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
How should you pick the next fundable research topic?
Recently viewed grants:
MicroRNA Regulated Macrophage Polarization in Adipose Tissue Inflammation
Diseases of Public Health Importance Training Grant
A new proteostasis checkpoint in Drosophila intestinal stem cells: implications for age-related tissue dysfunction
Biology and Function of the Bladder Umbrella Cell Paracellular Barrier
Maine SPF PFSII SEOW
Recently added grants:
Inference for interacting pathogens with mechanistic and phenomenological models
Role of the Inflammatory Cytokine Oncostatin-M in Promoting Atherosclerosis
Strain-specific Immunity to Plasmodium vivax malaria
TARGETING G(alpha)q AND SRC-3 SIGNALING AS A NOVEL THERAPEUTIC APPROACH IN MELANO
Human Tonsil Explants as A Novel Model for Studying Dengue Virus Infection
National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Special Emphasis Panel (ZRG1-BDCN-Q (40))
University of North Carolina Chapel Hill
Kandra, Kelly L; Ranney, Leah M; Lee, Joseph G L et al.
Physicians' attitudes and use of e-cigarettes as cessation devices, North Carolina, 2013.
PLoS One 9:e103462
Be the first to comment on Kurt Ribisl's grant
Share this grant: